Recombinant Adeno-Associated Viral Vectors

Recombinant adeno-associated viral vectors (rAAVs) are essential for advanced therapies, enabling precise genetic delivery. Their complexity demands rigorous analytical control to ensure quality and compliance. At Quality Assistance, we provide end-to-end solutions for rAAV development, including identity, purity, genome integrity, and stability testing. Our GxP-compliant environment and expert team deliver actionable insights to accelerate your programme.